Birdwatch Note
2023-01-23 23:42:37 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There is no evidence of data fraud with any approved Covid vaccination. A single contractor (of many) in Pfizer's initial trial has been accused of data-integrity issues: https://www.bmj.com/content/375/bmj.n2635 However, numerous 2022 meta-analyses have continued to find vaccination safe and effective enough: https://www.frontiersin.org/articles/10.3389/fmed.2022.1015184/full https://pubmed.ncbi.nlm.nih.gov/36505947/
Written by B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1617231374934593542
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1617669161123209217
- noteId - 1617669161123209217
- participantId - B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A
- noteAuthorParticipantId -
- createdAtMillis - 1674517357506
- tweetId - 1617231374934593542
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There is no evidence of data fraud with any approved Covid vaccination. A single contractor (of many) in Pfizer's initial trial has been accused of data-integrity issues: https://www.bmj.com/content/375/bmj.n2635 However, numerous 2022 meta-analyses have continued to find vaccination safe and effective enough: https://www.frontiersin.org/articles/10.3389/fmed.2022.1015184/full https://pubmed.ncbi.nlm.nih.gov/36505947/
Note Ratings
rated at | rated by | |
2023-01-24 12:18:46 -0600 | 0207D720549594A42BFF493418C77398B756A89A56CF9C47A4DAA73D864DD816 | Rating Details |
2023-01-24 11:14:35 -0600 | 0E3F6EB4AAF7233033251BACE0F0325D12DBDA5E1D67354D15807134017D9D96 | Rating Details |
2023-01-24 15:39:44 -0600 | 145B12B729F528A0BB39B6DA7FCD2D987C096D3DAD80D2B99E195DD96F146533 | Rating Details |
2023-01-23 22:12:31 -0600 | 183E0A4519C4C73D9F82EEF52B6C3AF56DF60FADD196E1D20DA22DF7DA13E2C1 | Rating Details |
2023-01-24 17:48:24 -0600 | 1860BBA81E7CB9ED68C672059BB20D97A573B6C7E46280DC9089BFC07776798D | Rating Details |
2023-01-25 05:13:22 -0600 | 1B3AABC40AD0516371578D6583EDFE631183D5EF6225A4E33B8D7B96A95C5373 | Rating Details |
2023-01-24 13:13:31 -0600 | 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 | Rating Details |
2023-01-23 19:16:35 -0600 | 1FDB22A43F03243806F235058C7EEF81B8015C76801FF0195816D9D151CCC7C2 | Rating Details |
2023-01-23 18:17:54 -0600 | 203BB148F081214D377008CF3141311F89C3B9E734649846D06BA49B250C3FE5 | Rating Details |
2023-01-24 14:01:47 -0600 | 248AF2C00311C9F2DD11E002DB33E10A8DC3628D3FBD291637F8070AF4799E42 | Rating Details |
2023-01-23 18:29:44 -0600 | 26DB99AA1615E6E9F997319CDAA88AC42BCE70F542D558C1767AAC543D2373FD | Rating Details |
2023-01-24 18:58:42 -0600 | 317EDDA69961E1D44F706832A36701B1FA496871E32CA46FE40E051F9D668626 | Rating Details |
2023-01-23 23:50:38 -0600 | 31A871715770F30DF9D90A0B7CECD8ACD5F3B78E6081D8ECB11FDEA06ADF36FC | Rating Details |
2023-01-23 19:08:26 -0600 | 3392C3F9B21867C8AF904652558C946223E3E94992B330A505911FF07B2A09B0 | Rating Details |
2023-01-24 10:26:43 -0600 | 3440E327FFC09396E77E3C806B2CE63500A27905ABDA4DA599C2EFB3935307B4 | Rating Details |
2023-01-24 02:21:42 -0600 | 3E43C30DFEEF19A4BA0EFE1E78A730455FA07A446BE71F2B8324CB307921EAB8 | Rating Details |
2023-01-24 07:17:07 -0600 | 3EF0CDD07248880CDA7B2E598EC63D15B0DD871B4FC420787CF032405F50FA3C | Rating Details |
2023-01-24 14:50:04 -0600 | 4041D094A303FDDA33786E1B07983E08AD937C19220AF900C780C64DC8FACE84 | Rating Details |
2023-01-24 05:21:41 -0600 | 4BB61D65D7545639664716EAE56CDBF3F5C9088604F0293D4994C350716F3DFB | Rating Details |
2023-01-24 16:24:18 -0600 | 4CFF19BD69F823E18A5AFBF5CD7648436BD1D8B0C02EBB4B6789AA19064063E0 | Rating Details |
2023-01-23 18:25:44 -0600 | 55DD8845CB36D4A3C8FF939830B75C3B46088E7B5C2E475F714CFB4866CD4249 | Rating Details |
2023-01-24 15:12:35 -0600 | 5B66C2C2840AD455FDAC3D1F25BF92AD35DB04D16E6BE11F99C2E62BAC83F418 | Rating Details |
2023-01-24 10:34:45 -0600 | 7BCD718E512E446AEF4EA3476701A4B5789C4CE1DA7ED8BB1EB537225876EA93 | Rating Details |
2023-01-24 16:33:19 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
2023-01-23 21:48:41 -0600 | 8397B8EFF5E66D74E3D766849AAD6651C15A83BE48BE57BF0E5A1A8D5A1A4AE7 | Rating Details |
2023-01-24 07:11:58 -0600 | 86F78E685E3698841326A86187C7EDC3F8FB3847E1F5A434D2490AFCD65F2858 | Rating Details |
2023-01-24 17:50:18 -0600 | 89B56AF46E7F8E46C18F33232D7E0ADE06FBA5087925E8BB30F82C7BCB25A1CE | Rating Details |
2023-01-24 17:27:52 -0600 | 91ED1050C69AB445CFA549CAAF55F48AAC56D267EAADDF024A57D453A99233C4 | Rating Details |
2023-01-23 17:51:26 -0600 | 992932B0527A672C23AE61796C01072F45C13496756A150528BB74653898B6D4 | Rating Details |
2023-01-23 20:55:42 -0600 | 99A04DBEE564ECFE86E3460BF91DAB57A3565292D63504E942EAC2F1417B1B67 | Rating Details |
2023-01-23 20:08:21 -0600 | A32798EEEE1E44F0463D1319AC009549D2ED9B3CD1AF04B9825DFF932C0CAE7A | Rating Details |
2023-01-24 02:08:17 -0600 | A62CB1E3D435712357772B9D251C04F1B06800D0CA94F5576116AC3904C1071F | Rating Details |
2023-01-24 20:45:34 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2023-01-23 22:53:17 -0600 | AB062C23E1BE3FF6E8FD6ED73665DA3041877410026A7EB15E38F5EAA054F5CF | Rating Details |
2023-01-24 16:10:44 -0600 | BC1FD92D4650BDAE74B03FCAB57D2DD3A0E369957816F5517D11A1A50AEC9838 | Rating Details |
2023-01-23 17:56:27 -0600 | C4AB10E196962EA212F4C3584870BD8DB89E319FC530438A8AA8E5A0F039EEC9 | Rating Details |
2023-01-24 11:19:36 -0600 | C529E35959D89D8A3446BAA4DC351E09C78515B8691E0E31BFB866CFFE478AD1 | Rating Details |
2023-01-23 17:49:13 -0600 | C559E982739691E2EFE38F13A971AA3B8B28A962694A86631FB41C5B2274E6C4 | Rating Details |
2023-01-24 16:17:56 -0600 | C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B | Rating Details |
2023-01-24 11:31:18 -0600 | CBA172B1A9DDD1D441CC406C9B5A86649F3276EF6010807F0D6014186A3E9F9A | Rating Details |
2023-01-23 23:43:25 -0600 | D45A2C2D0A01452EB4CAC563989CA4D4828760FB2A92310BCB8E87CE1A83E5A9 | Rating Details |
2023-01-24 12:34:40 -0600 | DC1B038605EB7B153771BACDFFE6C9D25363704191B3240E4AAC28B7E18C77A6 | Rating Details |
2023-01-24 05:26:28 -0600 | E02B39324264A848F4272C83E565B2E9FC2A3FD268BFE5D1663197769B8348B8 | Rating Details |
2023-01-24 22:27:53 -0600 | E343F092F0B44A6E8DEC7F3A16DFE90A5DA9F420CB1B9EDE2292D0B45E00C827 | Rating Details |
2023-01-24 16:05:18 -0600 | E57C0FFC9E835767BFC8247799F09FE811C0EDDDE7D357C699FE8EF7430E8DFB | Rating Details |
2023-01-24 17:18:12 -0600 | F6EDD0EE9AD34206AB0E013BA0BD0FEDB50ADE7F0BB4F2B4734E0BCF37CF2163 | Rating Details |
2023-01-24 02:19:05 -0600 | Rating Details | |
2023-01-23 19:32:41 -0600 | Rating Details | |
2023-01-24 16:17:56 -0600 | Rating Details | |
2023-01-23 20:08:21 -0600 | Rating Details | |
2023-01-24 05:21:41 -0600 | Rating Details | |
2023-01-24 17:48:24 -0600 | Rating Details | |
2023-01-24 17:27:52 -0600 | Rating Details | |
2023-01-24 13:13:31 -0600 | Rating Details | |
2023-01-24 07:11:58 -0600 | Rating Details | |
2023-01-24 10:34:45 -0600 | Rating Details | |
2023-01-23 17:49:13 -0600 | Rating Details | |
2023-01-23 18:17:54 -0600 | Rating Details | |
2023-01-23 23:43:25 -0600 | Rating Details | |
2023-01-24 20:45:34 -0600 | Rating Details | |
2023-01-24 12:18:46 -0600 | Rating Details | |
2023-01-24 22:27:53 -0600 | Rating Details | |
2023-01-24 16:10:44 -0600 | Rating Details | |
2023-01-24 17:50:18 -0600 | Rating Details | |
2023-01-24 07:17:07 -0600 | Rating Details | |
2023-01-24 11:31:18 -0600 | Rating Details | |
2023-01-23 21:48:41 -0600 | Rating Details | |
2023-01-24 14:01:47 -0600 | Rating Details | |
2023-01-23 17:56:27 -0600 | Rating Details | |
2023-01-23 17:51:26 -0600 | Rating Details | |
2023-01-23 22:12:31 -0600 | Rating Details | |
2023-01-24 05:26:28 -0600 | Rating Details | |
2023-01-24 02:08:17 -0600 | Rating Details | |
2023-01-24 15:39:44 -0600 | Rating Details | |
2023-01-23 18:25:44 -0600 | Rating Details | |
2023-01-24 16:33:19 -0600 | Rating Details | |
2023-01-23 19:16:35 -0600 | Rating Details | |
2023-01-23 22:53:17 -0600 | Rating Details | |
2023-01-24 15:12:35 -0600 | Rating Details | |
2023-01-24 18:58:42 -0600 | Rating Details | |
2023-01-24 11:19:36 -0600 | Rating Details | |
2023-01-24 14:50:04 -0600 | Rating Details | |
2023-01-24 11:14:35 -0600 | Rating Details | |
2023-01-24 10:26:43 -0600 | Rating Details | |
2023-01-24 17:18:12 -0600 | Rating Details | |
2023-01-24 02:21:42 -0600 | Rating Details | |
2023-01-23 18:29:44 -0600 | Rating Details | |
2023-01-24 02:19:05 -0600 | Rating Details | |
2023-01-24 16:05:18 -0600 | Rating Details | |
2023-01-25 05:13:22 -0600 | Rating Details | |
2023-01-23 19:08:26 -0600 | Rating Details | |
2023-01-23 20:55:42 -0600 | Rating Details | |
2023-01-23 19:32:41 -0600 | Rating Details | |
2023-01-24 16:24:18 -0600 | Rating Details | |
2023-01-23 23:50:38 -0600 | Rating Details | |
2023-01-24 12:34:40 -0600 | Rating Details | |
2023-07-11 10:53:41 -0500 | Rating Details | |
2023-07-11 05:37:42 -0500 | Rating Details | |
2023-07-11 04:46:52 -0500 | Rating Details | |
2023-07-11 03:05:11 -0500 | Rating Details | |
2023-07-11 02:55:59 -0500 | Rating Details |